Dextroamphetamine and amphetamine combination therapy
Pro Research Analysisby 
Searched over 200M research papers
Dextroamphetamine and Amphetamine Combination Therapy: Clinical Uses and Efficacy
ADHD and Comorbid Conditions: Dextroamphetamine/Amphetamine Effectiveness
Dextroamphetamine and amphetamine combination therapy is widely recognized as a first-line treatment for attention-deficit/hyperactivity disorder (ADHD) in adults. Clinical trials show that dextroamphetamine significantly reduces ADHD symptoms compared to placebo, with a high proportion of patients responding positively to the medication. However, when combined with other medications like paroxetine, the risk of adverse events increases without additional benefit in symptom improvement. The presence of comorbid mood or anxiety disorders may reduce the response to dextroamphetamine, but overall, medication combined with psychological therapy leads to greater improvement than therapy alone . In cases where ADHD is comorbid with borderline personality disorder (BPD), case reports suggest that dextroamphetamine/amphetamine therapy can improve both ADHD and BPD-related functional impairments, possibly by enhancing the patient’s ability to engage in behavioral therapies .
Treatment-Resistant Depression: Adjunctive Use of Dextroamphetamine/Amphetamine
For patients with treatment-resistant depression (TRD), where standard antidepressant therapies have failed, there is emerging evidence that adjunctive therapy with amphetamine and dextroamphetamine (such as Adderall) can provide significant relief of depressive symptoms. This effect has been observed even after other pharmacologic and non-pharmacologic interventions, such as transcranial magnetic stimulation, have failed. However, such cases are rare and more research is needed to establish the efficacy and safety of this approach in broader populations .
Poststroke Recovery: Dextroamphetamine in Motor and Language Rehabilitation
The use of dextroamphetamine in combination with physical therapy for poststroke motor recovery has produced mixed results. Some studies report that pairing dextroamphetamine with physical therapy accelerates and enhances motor recovery in stroke patients, with benefits persisting up to a year after treatment . However, larger and more recent clinical trials have not found significant differences in motor recovery between dextroamphetamine and placebo groups, though the treatment was found to be safe . In the context of poststroke aphasia, combining dextroamphetamine with transcranial direct current stimulation and speech therapy appears safe and may improve speech and language performance, but further research is needed to confirm these findings .
Sleep Disorders: Amphetamine-Dextroamphetamine Versus Modafinil
For idiopathic hypersomnia and narcolepsy type 2, amphetamine-dextroamphetamine is commonly used as an alternative to modafinil. Recent randomized trials show that while amphetamine-dextroamphetamine may not be non-inferior to modafinil for reducing sleepiness as measured by the Epworth Sleepiness Scale, it is non-inferior for other important symptoms such as disease severity, sleep inertia, and cognitive symptoms. Adverse event rates are similar between the two drugs, though appetite suppression is more common with amphetamine-dextroamphetamine 59.
Sexual Dysfunction: Amphetamine/Dextroamphetamine for Delayed Orgasm and Anorgasmia
Preliminary studies suggest that amphetamine/dextroamphetamine salts may improve symptoms of delayed orgasm and anorgasmia in men, particularly in those who have not responded to other treatments. About one-third of patients experienced measurable improvements in orgasmic latency or frequency, with minimal side effects reported. However, larger studies are needed to confirm these findings and establish clear treatment guidelines .
Pain Management: Dextroamphetamine as an Analgesic Adjunct
When combined with morphine for postoperative pain, dextroamphetamine enhances the analgesic effect of morphine, making the combination more potent than morphine alone. Additionally, dextroamphetamine can offset some of the undesirable side effects of morphine, such as sedation and loss of alertness, without causing significant changes in vital signs .
Conclusion
Dextroamphetamine and amphetamine combination therapy is effective for ADHD and may have benefits in other conditions such as treatment-resistant depression, poststroke recovery, sleep disorders, sexual dysfunction, and pain management. While evidence supports its use in several areas, the efficacy and safety profile can vary depending on the condition and patient population. More research is needed to clarify its role in complex or comorbid conditions and to optimize treatment protocols for broader clinical use.
Sources and full results
Most relevant research papers on this topic